Sign in

You're signed outSign in or to get full access.

Lawrence Kurzius

Director at Lamb Weston HoldingsLamb Weston Holdings
Board

About Lawrence E. Kurzius

Lawrence E. “Larry” Kurzius (age 67) is an independent director of Lamb Weston (LW), appointed in July 2025 as part of a Cooperation Agreement-driven board refresh. He is the former Executive Chairman and prior Chair/CEO of McCormick & Company; he holds a B.A. in Economics from Princeton University and currently serves as Chairman of Elanco Animal Health and as a director of The Cooper Companies .

Past Roles

OrganizationRoleTenureCommittees/Impact
McCormick & CompanyExecutive ChairmanAug 2023 – Dec 2024Led sustainability and purpose-led performance initiatives; UN Global Compact LEAD recognition cited .
McCormick & CompanyChair and Chief Executive OfficerChair: Feb 2017 – Aug 2023; CEO: Feb 2016 – Aug 2023Oversaw global CPG operations; leadership across strategy, risk/compliance, and human capital .
McCormick & CompanyPresident & COO; President, Global Consumer2015 – 2016 (P/COO); 2013 – 2016 (Global Consumer)Operational leadership in consumer business .
McCormick & CompanyChief Administrative Officer2013 – 2015Enterprise administration .
McCormick & CompanyPresident, International; President, EMEA; President, U.S. Consumer FoodsVarious (joined 2003)International expansion and operations leadership .
Zatarain’s BrandsChief Executive Officerc. 1991–2003 (12 years pre-acquisition)Led national food/spice company acquired by McCormick .
Quaker Oats; Mars, Inc.Marketing executivePrior to Zatarain’sBrand and consumer marketing in food CPG .

External Roles

OrganizationRoleSinceNotes
Elanco Animal Health (ELAN)Chairman of the BoardDirector since Sep 2018Currently Chairman; ongoing governance leadership .
The Cooper Companies (COO)DirectorDec 2023Public company board experience; healthcare/med-tech exposure .
McCormick & Company (MKC)Director (prior)Dec 2015 – Mar 2025Ended board service before joining LW .

Board Governance

  • Independence and appointment: Classified as Independent; joined as an “Independent Mutual Director” mutually agreed by the Company and shareholder parties JANA Partners and Continental Grain under the June 30, 2025 Cooperation Agreement .
  • Committee assignments: Member, Compensation & Human Capital Committee; Member, Nominating & Corporate Governance Committee (not a chair) .
  • Board/committee activity levels: FY2025 meetings held — Board: 14; Audit: 6; Compensation: 5; Governance: 4. Company disclosed that, during the period served, each director attended at least 75% of applicable meetings in FY2025 (note: Mr. Kurzius joined post-FY2025 close) .
  • Leadership structure: Bradley A. Alford elected Chairman effective July 10, 2025; ex officio member of each committee .
  • ESG and risk oversight: Governance Committee oversees ESG strategy and board evaluation; Compensation Committee oversees human capital and risks in pay programs; Audit Committee oversees ERM, cybersecurity, and finance .
  • Anti-pledging/hedging; clawbacks: Directors are prohibited from hedging/pledging; company maintains clawback policies (Dodd-Frank and legacy) for executives .
  • Limits on outside boards: Policy caps most directors at four public company boards (including LW); Audit members capped at two other audit committees; all directors in compliance per proxy .

Fixed Compensation

ElementAmount/StructureNotes
Board cash retainer (pre-change)$100,000Paid quarterly; allowed deferral to cash/stock accounts under Directors’ Deferred Compensation Plan .
Committee chair retainersAudit: $25,000; Comp: $20,000; Governance: $15,000Cash; unchanged post-2025 changes .
Annual equity grant (pre-change)$170,000 in RSUsGranted at annual meeting; vests at next annual meeting or 1-year anniversary; dividend equivalents accrue; pro-rata vesting on certain separations .
2025 compensation actually paid (FY2025)$0 (for Kurzius)Joined July 2025; table notes he received no FY2025 director pay/awards .
Post-Annual Meeting 2025 changeBoard retainer 100% equity; annual equity grant value $270,000Board unanimously elected to shift to 100% equity retainer to enhance alignment; effective following 2025 Annual Meeting .
Appointment grants (Jul 2025 appointees)Prorated RSUs (100% equity)New July 2025 directors (incl. Kurzius) received prorated RSUs; Chairman received 50% options/50% RSUs for the chair retainer .

Performance Compensation

Program FeatureTermsAlignment/Notes
Director equity vehicleRSUs (service-vesting)Standard annual grant; no performance metrics for directors; dividend equivalents accrue in RSUs .
VestingEarlier of next annual meeting or 1-year anniversary; pro-rata on certain separations; full vesting on death/disabilityEnhances retention while maintaining service-based alignment .
Board retainer mix (effective post-2025 AM)100% equity; $270,000 annual valueClear shift toward equity alignment vs cash; committee chair retainers remain cash .
Deferral optionsCash retainers (pre-change) could be deferred to interest-bearing or LW stock accounts; directors may also defer stockNo above-market earnings; supports long-horizon alignment .

Note: Director compensation is service-based; no revenue/EBITDA/TSR performance metrics apply to non-employee director pay as disclosed .

Other Directorships & Interlocks

CompanyRolePotential Interlock/Note
Elanco Animal HealthChairmanAdditional leadership time commitment; no related-party transactions disclosed at LW .
The Cooper CompaniesDirectorHealthcare board perspective; no related-party transactions disclosed at LW .
McCormick & Company (prior)Former Chair/CEO; former director (through Mar 2025)McCormick appears in LW’s executive compensation peer group; Kurzius sits on LW’s Compensation Committee, which may raise optics but he no longer serves at McCormick .

Expertise & Qualifications

  • Leadership/CPG/Operations: Deep CPG operating experience across McCormick and prior roles (consumer trends, global operations, strategy) .
  • Risk/compliance and ESG: Led sustainability initiatives at McCormick; experience with UN Global Compact LEAD and ESG oversight; Governance/Comp committee service at LW .
  • Human capital: Experience leading a >14,000-employee organization; executive compensation and leadership development expertise .

Equity Ownership

HolderBeneficially Owned SharesDeferred Stock/Underlying UnitsTotal Shares/Interests% of OutstandingPledged?
Lawrence E. Kurzius01,1091,109<1% (aggregate for all individuals each <1%)None; proxy states no pledged shares for named individuals and prohibits pledging/hedging .
  • Director stock ownership guideline: 5x annual Board retainer ($500,000 under prior $100k cash retainer framework); directors must attain within five years of joining and may not sell until the guideline is met (except for taxes) .

Governance Assessment

  • Strengths for investor confidence

    • Independent director with extensive CPG operating and board leadership credentials (former McCormick CEO/Chair; current Elanco Chairman), positioned on Compensation and Governance committees where his experience is directly relevant .
    • Board shifted director retainer to 100% equity and added FCF/ROIC to executive incentives after shareholder feedback, signaling alignment and responsiveness; Kurzius joined amid this refresh .
    • No related-party transactions requiring disclosure in the most recent period; strong anti-hedging/pledging policies encompass directors .
  • Watch items / potential red flags

    • Optics: McCormick is included in LW’s compensation peer group while Kurzius serves on LW’s Compensation Committee and is the former McCormick CEO/Chair; he is no longer on McCormick’s board, but committees should continue to monitor for perceived bias in benchmarking .
    • Board refresh via Cooperation Agreement with activist shareholders (JANA, Continental Grain) adds pressure for performance and accountability; Kurzius is one of the mutually agreed independent additions, which increases expectations for decisive oversight and alignment with the settlement’s objectives .
    • Time commitments: Concurrent Elanco chairmanship and Cooper Companies directorship require attention to potential overboarding risk; LW policy caps are four public boards and the proxy states compliance, but ongoing monitoring of attendance remains prudent .
  • Attendance and engagement

    • Company disclosed each director attended ≥75% of meetings during the period served in FY2025; Board and committees conduct annual self-evaluations, with individual director interviews by the Governance Chair .
  • Compensation governance

    • Compensation Committee uses an independent consultant (F.W. Cook), maintains clawbacks (executive), prohibits hedging/pledging, and avoids option repricing—practices supportive of shareholder alignment; Kurzius sits on this committee .

Related Party Transactions and Conflicts

  • Policy requires pre-approval of related party transactions by the Audit Committee; none required disclosure since the beginning of the most recent fiscal year .
  • Anti-pledging/hedging restrictions apply to directors; none of the named individuals’ shares are pledged .

Director Compensation Reference (Structure)

Compensation ElementValue/TermSource
Board cash retainer (legacy)$100,000
Equity grant (legacy)$170,000 RSUs
Post-2025 shift100% equity retainer; $270,000 annual equity
Committee chair feesAudit $25k; Comp $20k; Governance $15k
New director (Jul 2025) treatmentProrated RSUs; no FY2025 compensation for July 2025 appointees
RSU vestingEarlier of next annual meeting or 1-year from grant; dividend equivalents accrue

Conclusion: Kurzius brings high-caliber CPG leadership, ESG and human capital oversight experience to LW, with committee placements that can enhance board effectiveness. Key monitoring items include perceived benchmarking optics given his McCormick background and continued delivery on activist-driven governance and performance commitments .